Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2199
2.880
Why?
Smoking
20
2019
1384
1.330
Why?
Bronchi
13
2018
232
1.270
Why?
Carcinoma in Situ
5
2019
44
1.150
Why?
Carcinoma, Squamous Cell
10
2018
584
0.800
Why?
Carcinogens
4
2012
105
0.790
Why?
Chemoprevention
3
2019
88
0.750
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.750
Why?
Lung
16
2020
3546
0.660
Why?
Carcinoma, Small Cell
7
2008
158
0.520
Why?
Bronchopulmonary Dysplasia
2
2019
331
0.510
Why?
Urethane
3
2012
41
0.500
Why?
Bronchoscopy
9
2019
246
0.490
Why?
Sputum
8
2019
285
0.480
Why?
Pulmonary Alveoli
4
2012
372
0.480
Why?
Iloprost
2
2012
46
0.470
Why?
Hyperplasia
7
2011
163
0.470
Why?
Precancerous Conditions
7
2020
158
0.460
Why?
Neprilysin
3
1998
47
0.430
Why?
Biomarkers, Tumor
7
2015
1053
0.430
Why?
Piperidines
2
2012
161
0.410
Why?
Antineoplastic Agents
4
2013
1895
0.410
Why?
Quinazolines
2
2012
243
0.400
Why?
Biopsy
11
2019
1040
0.400
Why?
DNA Copy Number Variations
1
2011
158
0.360
Why?
Genetic Markers
1
2011
321
0.360
Why?
Bombesin
5
1998
12
0.360
Why?
Amidohydrolases
3
1998
28
0.340
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
973
0.340
Why?
Neurosecretory Systems
4
2004
32
0.330
Why?
Mass Screening
3
2008
1003
0.330
Why?
Isotretinoin
1
2009
22
0.330
Why?
Ki-67 Antigen
3
2015
106
0.330
Why?
Tocopherols
1
2009
22
0.330
Why?
Vasodilator Agents
1
2011
303
0.330
Why?
ErbB Receptors
1
2012
560
0.320
Why?
Membrane Proteins
2
2008
1022
0.310
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
916
0.300
Why?
Neovascularization, Pathologic
6
2015
283
0.300
Why?
Respiratory Mucosa
2
2008
251
0.280
Why?
Adenocarcinoma
6
2012
801
0.270
Why?
Hypoxia
1
2012
957
0.260
Why?
Middle Aged
28
2019
26757
0.240
Why?
Aged
25
2019
19094
0.240
Why?
Chromosomes, Human, Pair 3
4
2000
49
0.230
Why?
Chromosome Aberrations
4
2013
138
0.220
Why?
Carcinoma, Bronchogenic
2
2002
17
0.220
Why?
Humans
53
2020
114757
0.210
Why?
Female
33
2019
59507
0.210
Why?
Tomography, Spiral Computed
1
2002
23
0.210
Why?
Sensitivity and Specificity
10
2010
1691
0.200
Why?
Double-Blind Method
2
2019
1662
0.190
Why?
Smokers
2
2019
128
0.190
Why?
Lung Diseases
5
2015
696
0.190
Why?
Tomography, X-Ray Computed
2
2020
2269
0.190
Why?
Male
30
2019
55579
0.190
Why?
Placebos
2
2019
198
0.190
Why?
Small Cell Lung Carcinoma
2
2012
82
0.190
Why?
Tumor Cells, Cultured
6
1998
854
0.170
Why?
Neuropeptides
4
1998
65
0.170
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
98
0.160
Why?
Remission Induction
1
2019
233
0.160
Why?
Peptides
3
1996
849
0.160
Why?
In Situ Hybridization, Fluorescence
6
2010
313
0.150
Why?
Blotting, Western
4
2012
1151
0.150
Why?
Lung Diseases, Obstructive
1
1997
40
0.150
Why?
Genes, p53
1
1997
62
0.150
Why?
Antibodies, Monoclonal
3
2010
1270
0.140
Why?
Proteomics
2
2015
843
0.140
Why?
Immunohistochemistry
8
2015
1635
0.140
Why?
Point Mutation
1
1997
216
0.140
Why?
Mice
10
2012
14916
0.130
Why?
Animals
13
2013
31762
0.130
Why?
Radiation Injuries, Experimental
1
1996
25
0.130
Why?
Bradykinin
1
1996
43
0.130
Why?
Endopeptidases
1
1996
71
0.130
Why?
Chromosomal Instability
2
2013
18
0.130
Why?
Smoking Cessation
1
2019
374
0.130
Why?
Risk Factors
5
2019
8627
0.120
Why?
Multiple Pulmonary Nodules
1
2015
22
0.120
Why?
Hyperoxia
1
1996
100
0.120
Why?
Aged, 80 and over
8
2015
6350
0.120
Why?
Gene Expression
3
1998
1420
0.120
Why?
Mice, Transgenic
5
2009
1951
0.120
Why?
Antigens
1
1996
318
0.120
Why?
Algorithms
3
2020
1468
0.110
Why?
Methylcholanthrene
2
2012
18
0.110
Why?
Mutation
4
2000
3350
0.110
Why?
Butylated Hydroxytoluene
2
2012
31
0.110
Why?
Stem Cells
1
2018
546
0.110
Why?
Microarray Analysis
1
2013
119
0.110
Why?
Epithelium
4
2018
297
0.110
Why?
Biological Products
1
1996
167
0.110
Why?
Intramolecular Oxidoreductases
2
2004
57
0.110
Why?
Epithelial Cells
3
2007
955
0.110
Why?
Risk
5
2012
815
0.100
Why?
Carcinoma, Large Cell
1
2012
14
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
108
0.100
Why?
Case-Control Studies
8
2012
3005
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
589
0.100
Why?
Receptors, Bombesin
1
2012
2
0.100
Why?
Volatile Organic Compounds
1
2012
45
0.100
Why?
Immunoenzyme Techniques
1
2012
195
0.100
Why?
Cell Division
4
2000
759
0.100
Why?
Veterans
1
2002
1240
0.100
Why?
Sleep Apnea Syndromes
1
2012
74
0.100
Why?
Dose-Response Relationship, Drug
2
2010
1846
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2012
115
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
168
0.090
Why?
Adult
16
2018
30548
0.090
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.090
Why?
Disease Progression
5
2018
2387
0.090
Why?
Antioxidants
2
2012
530
0.090
Why?
Genome-Wide Association Study
2
2013
1197
0.090
Why?
Calcium
1
1996
1103
0.090
Why?
Predictive Value of Tests
4
2009
1796
0.090
Why?
Proteins
1
1996
912
0.090
Why?
Cell Line
5
2013
2639
0.090
Why?
Plants, Toxic
1
1989
22
0.090
Why?
Cell Proliferation
2
2018
2196
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
386
0.080
Why?
Chromosome Deletion
1
1989
95
0.080
Why?
Bronchial Neoplasms
1
2009
14
0.080
Why?
Neoplasms, Glandular and Epithelial
1
2009
34
0.080
Why?
Neoplasm Invasiveness
4
2015
445
0.080
Why?
GPI-Linked Proteins
1
2008
54
0.080
Why?
Respiratory System
1
1989
137
0.080
Why?
Fluorescence
3
2009
148
0.070
Why?
Airway Obstruction
3
2009
168
0.070
Why?
Inflammation
1
2018
2481
0.070
Why?
Polymorphism, Genetic
1
2011
612
0.070
Why?
Alkaline Phosphatase
1
2008
143
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Fibroblasts
3
1998
838
0.070
Why?
Molecular Targeted Therapy
1
2010
347
0.070
Why?
Isoenzymes
1
2008
285
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
229
0.070
Why?
Cell Transformation, Neoplastic
1
2009
312
0.070
Why?
Early Detection of Cancer
1
2010
328
0.070
Why?
Pulmonary Surfactants
2
1999
100
0.070
Why?
Molecular Sequence Data
5
1998
2791
0.070
Why?
Exons
2
1998
303
0.070
Why?
Follow-Up Studies
2
2015
4420
0.070
Why?
MicroRNAs
1
2012
601
0.070
Why?
Polymorphism, Single Nucleotide
1
2013
1892
0.070
Why?
Biomarkers
3
2010
3416
0.070
Why?
ROC Curve
3
2015
445
0.070
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
797
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
368
0.060
Why?
Recombinant Proteins
3
1998
1233
0.060
Why?
RNA, Messenger
3
1998
2557
0.060
Why?
Polymerase Chain Reaction
3
1998
994
0.060
Why?
Protein Kinase Inhibitors
1
2010
795
0.060
Why?
Cytokines
1
2012
1843
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
26
0.060
Why?
Acromegaly
1
2004
12
0.060
Why?
Rats
4
2004
4943
0.060
Why?
Neoplasm Recurrence, Local
1
2009
863
0.060
Why?
Adrenocorticotropic Hormone
1
2004
129
0.060
Why?
Cross-Sectional Studies
2
2018
4409
0.050
Why?
Smoke
1
2004
123
0.050
Why?
Base Sequence
3
1998
2118
0.050
Why?
Solitary Pulmonary Nodule
1
2002
20
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Sex Factors
1
2007
1717
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
498
0.050
Why?
Pulmonary Fibrosis
2
1998
322
0.050
Why?
Radiation Dosage
1
2002
130
0.050
Why?
Hospitals, Veterans
1
2002
244
0.050
Why?
Reproducibility of Results
1
2008
2763
0.050
Why?
Cohort Studies
4
2015
4901
0.040
Why?
Gene Expression Regulation
1
1989
2321
0.040
Why?
Feasibility Studies
1
2002
737
0.040
Why?
Amino Acid Sequence
3
1994
1988
0.040
Why?
Signal Transduction
3
1998
4522
0.040
Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
Why?
Light
1
2001
336
0.040
Why?
Autocrine Communication
1
1998
42
0.040
Why?
gamma Catenin
1
2018
17
0.040
Why?
Desmoglein 3
1
2018
17
0.040
Why?
Loss of Heterozygosity
2
2013
40
0.040
Why?
Gene Expression Profiling
1
2005
1521
0.040
Why?
Up-Regulation
2
2005
812
0.040
Why?
DNA Primers
2
1998
514
0.040
Why?
Paracrine Communication
1
1998
56
0.040
Why?
Bronchial Diseases
1
2018
38
0.040
Why?
United States
2
2011
12176
0.040
Why?
Neoplasm Transplantation
1
1998
232
0.040
Why?
Cell Cycle Checkpoints
1
2018
85
0.040
Why?
Time
1
2018
70
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
35
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
10
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
25
0.040
Why?
Genes, Tumor Suppressor
1
1998
77
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
86
0.040
Why?
Likelihood Functions
1
1998
126
0.040
Why?
Neoplasm Staging
2
2012
1176
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
65
0.040
Why?
DNA, Complementary
1
1998
257
0.040
Why?
Treatment Outcome
1
2011
9089
0.040
Why?
Gene Expression Regulation, Enzymologic
1
1998
271
0.040
Why?
Codon
1
1997
86
0.040
Why?
Introns
1
1998
227
0.040
Why?
Membrane Glycoproteins
1
1999
429
0.040
Why?
Mice, Nude
1
1998
635
0.030
Why?
Incidence
3
2010
2312
0.030
Why?
Machine Learning
1
2020
318
0.030
Why?
Immunoassay
2
1998
95
0.030
Why?
Enzyme Activation
1
1998
787
0.030
Why?
Image Processing, Computer-Assisted
1
2020
684
0.030
Why?
RNA, Neoplasm
1
1996
80
0.030
Why?
Mesothelioma
1
1996
31
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Antigens, CD
2
1998
443
0.030
Why?
Databases, Factual
1
2020
1128
0.030
Why?
Sequence Analysis, DNA
1
1998
728
0.030
Why?
Proto-Oncogene Proteins
1
2018
610
0.030
Why?
Cell Cycle Proteins
1
2018
552
0.030
Why?
Prospective Studies
3
2012
6217
0.030
Why?
Myelin Sheath
1
1996
144
0.030
Why?
Receptors, Peptide
1
1994
18
0.030
Why?
Liver Neoplasms
1
1998
507
0.030
Why?
Rh-Hr Blood-Group System
1
1994
11
0.030
Why?
Neoplasm Metastasis
1
1996
528
0.030
Why?
Erythrocyte Membrane
1
1994
50
0.030
Why?
Blotting, Southern
1
1993
68
0.030
Why?
Blotting, Northern
1
1993
193
0.030
Why?
Endoscopy
1
2015
248
0.030
Why?
Cells, Cultured
2
2007
3890
0.030
Why?
Colorado
1
2002
4086
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
1147
0.030
Why?
DNA, Neoplasm
1
1993
157
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Enzyme Inhibitors
1
1996
751
0.030
Why?
Dinoprostone
2
2004
184
0.030
Why?
Fluorescent Antibody Technique
1
1993
396
0.030
Why?
Breath Tests
1
2012
82
0.030
Why?
Gas Chromatography-Mass Spectrometry
1
2012
125
0.030
Why?
Cloning, Molecular
1
1993
524
0.030
Why?
Iceland
1
2011
6
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Respiratory Tract Diseases
1
1992
139
0.020
Why?
Spain
1
2011
32
0.020
Why?
Netherlands
1
2011
64
0.020
Why?
Rats, Sprague-Dawley
1
1996
2209
0.020
Why?
Cattle
1
1993
921
0.020
Why?
Administration, Oral
1
2012
731
0.020
Why?
Severity of Illness Index
1
2018
2539
0.020
Why?
Prognosis
2
2012
3334
0.020
Why?
Meta-Analysis as Topic
1
2011
161
0.020
Why?
Carrier Proteins
1
1994
696
0.020
Why?
Flow Cytometry
1
1993
1086
0.020
Why?
Receptor, IGF Type 1
1
2009
58
0.020
Why?
Area Under Curve
1
2010
275
0.020
Why?
Cystic Fibrosis
1
1998
955
0.020
Why?
International Agencies
1
2009
30
0.020
Why?
Erythrocytes
1
1994
591
0.020
Why?
Pilot Projects
1
2012
1370
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
472
0.020
Why?
Mass Spectrometry
1
2010
633
0.020
Why?
Genome, Human
1
2009
351
0.020
Why?
Models, Statistical
1
2010
604
0.020
Why?
Disease Models, Animal
1
1996
3542
0.020
Why?
Amino Acids
1
1989
448
0.020
Why?
Genotype
1
2011
1774
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
103
0.010
Why?
Genomics
1
2009
639
0.010
Why?
Epoprostenol
1
2004
133
0.010
Why?
Bronchiolitis
1
2004
81
0.010
Why?
Autoantibodies
1
2010
1350
0.010
Why?
Pituitary Neoplasms
1
2004
157
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
928
0.010
Why?
Fruit
1
2003
128
0.010
Why?
Genetic Predisposition to Disease
1
2011
2099
0.010
Why?
Vegetables
1
2003
133
0.010
Why?
Respiratory Function Tests
1
2004
524
0.010
Why?
Adenoma
1
2004
189
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
743
0.010
Why?
Weight Gain
1
2004
452
0.010
Why?
Regression Analysis
1
2003
946
0.010
Why?
Single-Blind Method
1
2001
258
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
57
0.010
Why?
Carcinoma
1
2001
198
0.010
Why?
RNA
1
2005
810
0.010
Why?
Retrospective Studies
1
2015
12515
0.010
Why?
Bronchoscopes
1
1998
4
0.010
Why?
Endoglin
1
1998
20
0.010
Why?
Random Allocation
1
1998
335
0.010
Why?
Reference Values
1
1998
742
0.010
Why?
Genetic Linkage
1
1998
297
0.010
Why?
Longitudinal Studies
1
2003
2386
0.010
Why?
Comorbidity
1
2001
1449
0.010
Why?
Tumor Suppressor Protein p53
1
2000
447
0.010
Why?
Diet
1
2003
1080
0.010
Why?
Linear Models
1
1998
770
0.010
Why?
Receptors, Cell Surface
1
1998
354
0.010
Why?
Young Adult
1
2011
10463
0.010
Why?
Analysis of Variance
1
1998
1226
0.010
Why?
Alleles
1
1998
791
0.010
Why?
Infant, Premature
1
1998
478
0.010
Why?
Risk Assessment
1
2004
2973
0.010
Why?
CD47 Antigen
1
1994
21
0.010
Why?
Chromatography, Affinity
1
1994
81
0.010
Why?
Endothelium, Vascular
1
2000
843
0.010
Why?
Moths
1
1994
35
0.010
Why?
Genes
1
1994
224
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
319
0.010
Why?
Cytoplasm
1
1994
255
0.010
Why?
Adolescent
1
2011
17808
0.010
Why?
Chromosome Mapping
1
1994
489
0.010
Why?
Carcinoid Tumor
1
1992
25
0.010
Why?
Lymphocytes
1
1994
332
0.010
Why?
Transfection
1
1994
870
0.010
Why?
Mice, Inbred BALB C
1
1994
1151
0.010
Why?
Dyspnea
1
1992
213
0.010
Why?
Binding Sites
1
1994
1176
0.010
Why?
Fibrosis
1
1992
453
0.010
Why?
Phenotype
1
1998
2812
0.010
Why?
Aging
1
1998
1620
0.000
Why?
Infant, Newborn
1
1998
5035
0.000
Why?
Infant
1
1998
7935
0.000
Why?
Child, Preschool
1
1998
9079
0.000
Why?
Child
1
1998
18352
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)